Bliss GVS Pharma Q1 FY2024 consolidated PAT up at Rs. 14.68 Cr
News

Bliss GVS Pharma Q1 FY2024 consolidated PAT up at Rs. 14.68 Cr

The company has reported total income of Rs. 164.63 crores during the period ended June 30, 2023

  • By IPP Bureau | August 02, 2023

Bliss GVS Pharma Limited has reported Standalone financial results for the period ended June 30, 2023.

The company has posted net profit of Rs. 14.68 crores for the period ended June 30, 2023 as against net profit of Rs. 3.34 crores for the period ended March 31, 2023.  It has posted net profit of Rs.25.71crores for the period ended June 30, 2022

The company has reported total income of Rs. 164.63 crores during the period ended June 30, 2023 as compared to Rs. 187.75 crores during the period ended March 31, 2023. It has reported total income of Rs.195.67 crores during the period ended June 30, 2022.

Upcoming E-conference

Other Related stories

Startup

Digitization